Aemetis Reports Third Quarter 2022 Financial Results

Rhea-AI Summary

Aemetis, Inc. (NASDAQ:AMTX) reported a 44% revenue increase for Q3 2022, totaling $71.8 million compared to $50 million in Q3 2021, driven by ethanolsales and India biodiesel shipments. However, the EPS was $(0.46), impacted by a $1.55 per share preferred shareholder redemption charge. Significant capital investments of $13.7 million in carbon reduction projects were made. The net loss for Q3 was $69.8 million, partly due to a one-time redemption charge. Year-to-date revenue reached $190 million, with gross losses of $4.4 million. Aemetis closed $25 million in project financing and made advancements in low carbon initiatives.

Positive

• 44% revenue growth in Q3 2022 to $71.8 million.
• $25 million project financing received from USDA for biogas projects.
• Milestones achieved including operational management transfer and completion of off-take agreements worth $3.8 billion for sustainable aviation fuel.

Negative

• Net loss increased to $69.8 million in Q3 2022 from $17.6 million in Q3 2021.
• EPS of $(0.46) impacted by a $53.9 million preferred shareholder redemption charge.
• Total gross loss of $4.4 million for the first nine months of 2022.

Revenue Increased 44% over Q3 2022; EPS was $(0.46), Excluding Preferred Shareholder Redemption Charge related to Biogas Minority Investor

CUPERTINO, CA / ACCESSWIRE / November 3, 2022 / Aemetis, Inc. (NASDAQ:AMTX), a renewable natural gas and renewable fuels company focused on negative carbon intensity products, today announced its financial results for the three and nine months ended September 30, 2022.

"Revenues for the third quarter of 2022 increased 44% to $71.8 million compared to $50 million during the third quarter of 2021 as ethanol sales increased to 15.7 million gallons in the quarter while the India biodiesel plant began shipments to Indian oil marketing companies' in mid-September and generated $11 million of revenues in about two weeks under this tender offer," said Todd Waltz, Chief Financial Officer of Aemetis. "Capital investment in multiple projects that reduce carbon intensity were $13.7 million for the third quarter of 2022 and $37.2 million year to date for 2022, as our engineering and construction teams moved forward with initiatives across our biogas, sustainable aviation fuel, renewable diesel, carbon capture, and low carbon renewable ethanol businesses," added Waltz.

Earnings per share (EPS) was $(0.46) in Q3 2022, before a shareholder redemption charge of an estimated $1.55 per share to reflect the planned redemption of all of the outstanding preferred ownership in Aemetis Biogas. Aemetis owns 100% of the common units of Aemetis Biogas and plans to repurchase 100% of the preferred units to become the sole equity owner of the biogas project. The redemption charge reflects the expected valuation premium for the redemption of the preferred units by Aemetis.

Aemetis recently closed a $25 million project financing supported by the US Department of Agriculture Renewable Energy for America Program (REAP) to fund the construction of dairy biogas digesters and biogas pipelines to produce Renewable Natural Gas (RNG). The financing was completed at a 5.95% interest rate and 0.25% USDA annual renewal fee which are fixed for five years, and has a highly favorable, 20-year repayment of principal.

"We are pleased with the milestones accomplished during 2022, including the transfer to Aemetis of operational management of the 125-acre Riverbank Industrial Complex for our sustainable aviation fuel (SAF) and renewable diesel (RD) plant projects; the purchase of 24 acres at the Riverbank site for carbon capture and sequestration injection wells; and completion of off-take agreements for $3.8 billion of sustainable aviation fuel with major airlines and $3.2 billion of renewable diesel to fully contract the SAF/RD plant volumes for project financing," said Eric McAfee, Chairman and CEO of Aemetis. "The Aemetis Biogas RNG project is on schedule for an expected Q1 2023 In Service acceptance of several components of the project, including: five additional dairy digesters; the Aemetis 40-mile biogas pipeline is completing construction and testing; the centralized biogas-to-RNG production facility is now in test and commissioning; and the RNG gas pipeline interconnection with PG&E is currently being tested," added McAfee.

"Importantly, we closed and received funding of about $50 million from two lower-interest-rate credit facilities that provide up to $100 million of new financing in the aggregate, subject to availability terms, to fund the pre-project financing of the carbon reduction projects at the Keyes ethanol plant and to fund the pre-project financing of land, engineering, permitting, test wells and related equipment for the renewable jet/diesel plant and the pre-project financing of two CO₂ sequestration wells", McAfee stated.

These milestones reflect execution of the projects outlined in the Aemetis Five-Year Plan that are expected to produce negative carbon intensity products and rapidly grow value for Aemetis shareholders. We invite investors to review the Aemetis Corporate Presentation on the Aemetis home page prior to the earnings call.

Today, Aemetis will host an earnings review call at 11:00 a.m. Pacific time (PT).

Live Participant Dial In (Toll Free): +1-888-506-0062 entry code 674127
Live Participant Dial In (International): +1-973-528-0137 entry code 674127

Webcast URL: https://www.webcaster4.com/Webcast/Page/2211/46959

For details on the call, please visit http://www.aemetis.com/investors/conference-calls/

Financial Results for the Three Months Ended September 30, 2022

Revenues during the third quarter of 2022 increased 44% to $71.8 million compared to $50 million for the third quarter of 2021. Our California Ethanol operations experienced steady sales price with an increase in the volume of ethanol sold from 13.8 million gallons in the third quarter of 2021 to 15.7 million gallons in the third quarter of 2022. Delivered corn price increased from an average price of $7.99 per bushel during the third quarter of 2021 to $9.59 per bushel during the third quarter of 2022. Our India Biodiesel segment began delivering under a tender offer in mid-September, delivering $11 million of biodiesel in about two weeks.

Gross loss for the third quarter of 2022 was $1.1 million, compared to $4.8 million gross loss during the third quarter of 2021. Our California Ethanol segment accounted for $3.8 million gross loss, with offsetting gross profits of $2.8 million from our India Biodiesel segment.

Selling, general and administrative expenses were $6.9 million during the third quarter of 2022, compared to $5.1 million during the third quarter of 2021 as a result of investments in our ultra-low carbon initiatives and non-cash charges for stock compensation.

Operating loss was $7.6 million for the third quarter of 2022, compared to an operating loss of $9.9 million for the third quarter of 2021.

Interest expense during the third quarter of 2022 was $7.1 million, excluding accretion and other expenses in connection with Series A preferred units in our Aemetis Biogas LLC subsidiary, compared to $5.5 million during the third quarter of 2021. Additionally, our Aemetis Biogas LLC subsidiary recognized $1.3 million of accretion and other expenses in connection with preference payments on its Series A preferred units during the third quarter of 2022 compared to $2.2 million during the third quarter of 2021 along with a loss on extinguishment on the Series A preferred units of an estimated $53.9 million during the third quarter of 2022 as a result of a charge related to the redemption of the Series A preferred units as part of the amendment to the Preferred Unit Purchase Agreement. The redemption charge reflects the expected valuation premium for the redemption of the Series A preferred units by Aemetis. We engaged third parties to assist with the accounting and fair value calculations. We are completing our final review of the accounting and related charge, and at this time we do not believe the amount will change materially in the third quarter 10Q to be filed subsequently to this earnings release.

Net loss was $69.8 million for the third quarter of 2022, compared to a net loss of $17.6 million for the third quarter of 2021 driven primarily from the one-time unitholder redemption charge of $53.9 million or $1.55 per share. Absent this one-time charge, the net loss was $16 million representing $0.46 per share.

Cash at the end of the third quarter of 2022 was $251,000, compared to $7.8 million at the close of the fourth quarter of 2021. Investments in capital projects of $13.7 million were made during the third quarter of 2022 further highlighting our commitment to build ultra-low carbon projects.

Financial Results for the Nine Months Ended September 30, 2022

Revenues were $190.0 million for the first nine months of 2022, compared to $147.6 million for the nine months of 2021, driven by an increase in the selling price of ethanol to $2.86 per gallon from $2.49 per gallon on sales of 45.5 million gallons compared to 44.6 million gallons during the same period of 2021 along with sales of 7,000 metric tons of biodiesel at an average price of $1,550 per metric ton during the nine months ended September 30, 2022.

Gross loss for the nine months ended September 30, 2022 was $4.4 million, compared to a gross profit of $4.7 million during the first nine months of 2021, as the delivered corn price increased to $9.53 per bushel during the first nine months of 2022 from $7.62 per bushel during the same period of 2021 in a market where ethanol experienced similar price increases.

Selling, general and administrative expenses were $21.2 million during the nine months ended September 30, 2022, compared to $16.2 million during the first nine months of 2021, primarily attributable to non-cash stock compensation expense.

Operating loss was $25.7 million for the nine months ended September 30, 2022, compared to $21.0 million for the first nine months of 2021.

Interest expense was $20.0 million during the nine months ended September 30, 2022, excluding accretion and other expenses of Series A preferred units in our Aemetis Biogas LLC subsidiary, compared to interest expense of $17.9 million during the first nine months of 2021. Additionally, our Aemetis Biogas LLC subsidiary recognized $4.4 million of accretion and other expenses in connection with preference payments on its Series A preferred units during the first nine months of 2022 compared to $7.9 million during the same period of 2021 along with a loss on extinguishment on the Series A preferred units of an estimated $53.9 million during the third quarter of 2022 as a result of a charge related to the redemption of the Series A preferred units as part of the amendment to the Preferred Unit Purchase Agreement. The redemption charge reflects the expected valuation premium for the redemption of the Series A preferred units by Aemetis.

Net loss for the nine months ended September 30, 2022, was $88.3 million, compared to a net loss of $46.3 million during the same period of 2021. Included in net income for the nine months of 2022 is the receipt of a grant of $14.2 million from the from the United States Department of Agriculture (USDA) Biofuel Producer Program and the one-time unitholder redemption charge.

Investments in capital projects of $37.2 million were made during the first nine months of 2022 further indicating progress on our carbon intensity reduction projects.

About Aemetis

Aemetis has a mission to transform renewable energy with below zero carbon intensity transportation fuels. Aemetis has launched the Carbon Zero production process to decarbonize the transportation sector using today's infrastructure.

Aemetis Carbon Zero products include zero-carbon fuels that can "drop-in" to be used in airplanes, truck, and ship fleets. Aemetis low-carbon fuels have substantially reduced carbon intensity compared to standard petroleum fossil-based fuels across their lifecycle.

Headquartered in Cupertino, California, Aemetis is an international renewable natural gas and renewable fuels, company focused on the acquisition, development, and commercialization of innovative technologies that replace petroleum-based products and reduce greenhouse gas emissions. Founded in 2006, Aemetis has completed Phase 1 and is expanding a California biogas digester network and pipeline system to convert dairy waste gas into Renewable Natural Gas (RNG). Aemetis owns and operates a 65 million gallon per year ethanol production facility in California's Central Valley near Modesto that supplies about 80 dairies with animal feed. Aemetis also owns and operates a 50 million gallon per year production facility on the East Coast of India, producing high-quality distilled biodiesel and refined glycerin for customers in India and Europe. Aemetis is developing the Carbon Zero Sustainable Aviation Fuel (SAF) and renewable diesel fuel biorefineries in California from renewable oils and orchard and forest waste. Aemetis holds a portfolio of patents and exclusive technology licenses to produce renewable fuels and biochemicals. For additional information about Aemetis, please visit www.aemetis.com.

NON-GAAP FINANCIAL INFORMATION

We have provided non-GAAP measures as a supplement to financial results based on GAAP. A reconciliation of the non-GAAP measures to the most directly comparable GAAP measures is included in the accompanying supplemental data. Adjusted EBITDA is defined as net income/(loss) plus (to the extent deducted in calculating such net income) interest expense, gain on extinguishment, income tax expense, intangible and other amortization expense, accretion expense, depreciation expense, gain on litigation, and share-based compensation expense.

Adjusted EBITDA is not calculated in accordance with GAAP and should not be considered as an alternative to net income/(loss), operating income or any other performance measures derived in accordance with GAAP or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA is presented solely as a supplemental disclosure because management believes that it is a useful performance measure that is widely used within the industry in which we operate. In addition, management uses Adjusted EBITDA for reviewing financial results and for budgeting and planning purposes. Adjusted EBITDA measures are not calculated in the same manner by all companies and, accordingly, may not be an appropriate measure for comparison between companies.

Safe Harbor Statement

This news release contains forward-looking statements, including statements regarding our assumptions, projections, expectations, targets, intentions or beliefs about future events or other statements that are not historical facts. Forward-looking statements in this news release include, without limitation, statements relating to our five-year growth plan; trends in market conditions with respect to prices for inputs for our products versus prices for our products; our ability to fund, develop, build, maintain and operate digesters, facilities and pipelines for our Dairy Renewable Natural Gas segment; our ability to fund, develop and operate our Carbon Capture and Sequestration projects, including obtaining required permits; our ability to receive awarded grants by meeting all of the required conditions, including meeting the minimum contributions; our ability to fund, develop and operate our sustainable aviation fuel and renewable biodiesel projects; our intention to repurchase the Series A preferred units relating to our Aemetis Biogas subsidiary and the expected valuation premium thereof; and our ability to raise additional capital. Words or phrases such as "anticipates," "may," "will," "should," "could," "believes," "estimates," "expects," "intends," "plans," "predicts," "projects," "targets," "will likely result," "will continue" or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on current assumptions and predictions and are subject to numerous market risks, uncertainties and other risks detailed in our reports filed with the Securities and Exchange Commission ("SEC"), including our Annual Report on Form 10-K for the year ended December 31, 2021, our Quarterly Report on Form 10-Q for the quarters ended March 31, 2022, June 30, 2022, and September 30, 2022 and in our subsequent filings with the SEC. Actual results or events could differ materially from those set forth or implied by such forward-looking statements and related assumptions due to certain factors, including, without limitation, competition in the ethanol, biodiesel and other industries in which we operate, commodity market risks including those that may result from current weather conditions, financial market risks, customer adoption, counter-party risks, risks associated with changes to federal policy or regulation. We are not obligated, and do not intend, to update any of these forward-looking statements at any time unless an update is required by applicable securities laws.

(Tables follow)

AEMETIS, INC.
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
(unaudited, in thousands except per share data)

		Three months ended								Nine months ended
		September 30,								September 30,
		2022				2021				2022				2021
Revenues		$	71,831			$	49,895			$	189,781			$	147,586
Cost of goods sold			72,935				54,680				194,184				152,333
Gross loss			(1,104	)			(4,785	)			(4,403	)			(4,747	)
Research and development expense			52				22				139				66
Selling, general and admin. expense			6,867				5,087				21,234				16,222
Other operating income			(428	)			-				(68	)			-
Operating loss			(7,595	)			(9,894	)			(25,708	)			(21,035	)
Interest expense
Interest rate expense			5,456				4,408				14,819				14,902
Debt related fees and Amortization expense			1,633				1,140				5,199				3,045
Accretion and other expenses of Series A preferred units			1,274				2,185				4,420				7,928
Loss (gain) on debt extinguishment			53,886				--				53,886				(1,134	)
Gain on litigation			-				--				(1,400	)			-
Other (income) expense			(2	)			(30	)			(14,297	)			483
Loss before income taxes			(69,842	)			(17,597	)			(88,335	)			(46,259	)
Income tax expense			3				--				13				7
Net loss		$	(69,845	)		$	(17,597	)		$	(88,348	)		$	(46,266	)
Net loss per common share
Basic		$	(2.01	)		$	(0.55	)		$	(2.57	)		$	(1.55	)
Diluted		$	(2.01	)		$	(0.55	)		$	(2.57	)		$	(1.55	)
Weighted average shares outstanding
Basic			34,769				31,857				34,344				29,818
Diluted			34,769				31,857				34,344				29,818

AEMETIS, INC.
CONSOLIDATED CONDENSED BALANCE SHEETS
(Unaudited, in thousands)

		September 30, 2022				December 31, 2021
Assets
Current assets:
Cash and cash equivalents		$	251			$	7,751
Accounts receivable			9,127				1,574
Inventories			10,431				5,126
Prepaid and other current assets			4,242				6,242
Total current assets			24,051				20,693
Property, plant and equipment, net			169,485				135,101
Right-of-use and other assets			5,339				5,037
Total assets		$	198,875			$	160,831
Liabilities and stockholders' deficit
Current liabilities:
Accounts payable		$	33,938			$	16,415
Current portion of long term debt			10,204				8,192
Short term borrowings			18,816				14,586
Mandatorily redeemable Series B stock			3,992				3,806
Accrued property taxes			1,028				6,830
Accrued contingent litigation fees			-				6,200
Current portion of Series A preferred Units			112,401				3,169
Other liabilities			6,715				6,132
Total current liabilities			186,094				65,330
Total long term liabilities			200,671				215,739
Stockholders' deficit:
Series B convertible preferred stock			1				1
Common stock			35				33
Additional paid-in capital			226,883				205,305
Accumulated deficit			(409,575	)			(321,227	)
Accumulated other comprehensive loss			(5,234	)			(4,350	)
Total stockholders' deficit			(187,890	)			(120,238	)
Total liabilities and stockholders' deficit		$	198,8675			$	160,831

RECONCILIATION OF ADJUSTED EBITDA TO NET LOSS
(unaudited, in thousands)

	Three Months Ended								Nine Months Ended
	September 30,								September 30,
		2022				2021				2022				2021
Net loss		$	(69,845	)		$	(17,597	)		$	(88,348	)		$	(46,266	)
Adjustments:
Interest expense			7,089				5,548				20,018				17,947
Depreciation expense			1,378				1,342				4,039				4,106
Accretion and other expenses of Series A preferred units			1,274				2,185				4,420				7,928
Share-based compensation			1,545				285				4,934				1,401
Intangibles and other amortization			12				11				35				35
Loss (gain) on debt extinguishment			53,886								53,886				(1,134	)
Loss on lease termination			-				-				736				-
Gain on litigation			-				-				(1,400	)			-
Income tax expense			3				-				13				7
Total adjustments			65,187				9,371				86,681				30,290
Adjusted EBITDA(1)		$	(4,658	)		$	(8,226	)		$	(1,667	)		$	(15,976	)

⁽¹⁾ Included in Net Loss and Adjusted EBITDA is the cash receipt of a grant of $14.2 million from the United States Department of Agriculture ("USDA") Biofuel Producer Program.

PRODUCTION AND PRICE PERFORMANCE
(unaudited)

		Three months ended								Nine months
		September 30,								September 30,
		2022				2021				2022				2021
Ethanol
Gallons sold (in millions)			15.7				13.8				45.5				44.6
Average sales price/gallon		$	2.85			$	2.84			$	2.86			$	2.49
Percentage of nameplate capacity			114	%			100	%			110	%			108	%
WDG
Tons sold (in thousands)			102.4				93.2				306.8				298.6
Average sales price/ton		$	127			$	96			$	130			$	102
Delivered cost of corn
Bushels ground (in millions)			5.5				4.8				15.9				15.6
Average delivered cost / bushel		$	9.59			$	7.99			$	9.53			$	7.62
Dairy Renewable Natural Gas
MMBtu produced			16.8				13.1				45.7				24.1
Biodiesel
Metric tons sold (in thousands)			7.0				0.0				7.0				0.5
Average sales price/metric ton		$	1,550			$	0			$	1,550			$	1,024
Percentage of nameplate capacity			19	%			0	%			4	%			1	%
Refined glycerin
Metric tons sold (in thousands)			0.1				0.0				0.1				0.1
Average sales price/metric ton		$	934			$	0			$	934			$	956

External Investor Relations Contact:
Kirin Smith
PCG Advisory Group
(646) 863-6519
ksmith@pcgadvisory.com

Investor Relations/Media Contact
Todd Waltz
(408) 213-0940
investors@aemetis.com

SOURCE: Aemetis, Inc.

View source version on accesswire.com:
https://www.accesswire.com/723688/Aemetis-Reports-Third-Quarter-2022-Financial-Results

FAQ

What were Aemetis's revenue results for Q3 2022?

Aemetis reported Q3 2022 revenues of $71.8 million, a 44% increase from $50 million in Q3 2021.

What was the EPS for Aemetis in Q3 2022?

Aemetis's EPS for Q3 2022 was $(0.46), impacted by a preferred shareholder redemption charge.

What was the net loss for Aemetis in Q3 2022?

The net loss for Aemetis in Q3 2022 was $69.8 million, compared to a net loss of $17.6 million in Q3 2021.

What financing did Aemetis secure in Q3 2022?

Aemetis closed a $25 million project financing supported by the USDA for biogas project initiatives.

What are the key milestones achieved by Aemetis in 2022?

Key milestones include management transition of the Riverbank Industrial Complex and $3.8 billion sustainable aviation fuel off-take agreements.